168 related articles for article (PubMed ID: 33228588)
1. Risk stratification for prediction of locoregional recurrence in patients with pathologic T1-2N0 breast cancer after mastectomy.
Wang J; Tang Y; Jing H; Sun G; Jin J; Liu Y; Song Y; Wang W; Fang H; Chen B; Qi S; Ren H; Li N; Tang Y; Lu N; Yang Y; Yu Z; Wang S; Li Y
BMC Cancer; 2020 Nov; 20(1):1132. PubMed ID: 33228588
[TBL] [Abstract][Full Text] [Related]
2. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
[TBL] [Abstract][Full Text] [Related]
3. Are there patients with T1 to T2, lymph node-negative breast cancer who are "high-risk" for locoregional disease recurrence?
Mamtani A; Patil S; Stempel MM; Morrow M
Cancer; 2017 Jul; 123(14):2626-2633. PubMed ID: 28334423
[TBL] [Abstract][Full Text] [Related]
4. Identification of Risk Factors for Locoregional Recurrence in Breast Cancer Patients with Nodal Stage N0 and N1: Who Could Benefit from Post-Mastectomy Radiotherapy?
Jwa E; Shin KH; Lim HW; Jung SY; Lee S; Kang HS; Lee E; Park YH
PLoS One; 2015; 10(12):e0145463. PubMed ID: 26691445
[TBL] [Abstract][Full Text] [Related]
5. The effect of postmastectomy radiation therapy on high-risk patients with T1-2N0 breast cancer.
Luo C; Zhong X; Fan Y; Wang C; Wang Y; Luo T
Breast; 2021 Dec; 60():1-5. PubMed ID: 34455226
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for breast cancer patients with T1-2 tumors and 1-3 positive lymph nodes and the role of postmastectomy radiotherapy in these patients.
Zhao JM; An Q; Sun CN; Li YB; Qin ZL; Guo H; Zeng X; Zhang YT; Wei LL; Han N; Sun SC; Zhang N
Breast Cancer; 2021 Mar; 28(2):298-306. PubMed ID: 32940902
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for locoregional recurrence after mastectomy in stage T1 N0 breast cancer.
Hastings J; Iganej S; Huang C; Huang R; Slezak J
Am J Clin Oncol; 2014 Oct; 37(5):486-91. PubMed ID: 23428949
[TBL] [Abstract][Full Text] [Related]
8. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation the significance of tumor size.
Fodor J; Polgár C; Major T; Németh G
Strahlenther Onkol; 2003 Mar; 179(3):197-202. PubMed ID: 12627264
[TBL] [Abstract][Full Text] [Related]
9. Patterns and risk factors of locoregional recurrence in T1-T2 node negative breast cancer patients treated with mastectomy: implications for postmastectomy radiotherapy.
Abi-Raad R; Boutrus R; Wang R; Niemierko A; Macdonald S; Smith B; Taghian AG
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e151-7. PubMed ID: 21420245
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Molecular Subtype and Residual Disease on Locoregional Recurrence in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Postmastectomy Radiation.
Yang TJ; Morrow M; Modi S; Zhang Z; Krause K; Siu C; McCormick B; Powell SN; Ho AY
Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S495-501. PubMed ID: 26130454
[TBL] [Abstract][Full Text] [Related]
11. Minimal impact of postmastectomy radiation therapy on locoregional recurrence for breast cancer patients with 1 to 3 positive lymph nodes in the modern treatment era.
Miyashita M; Tada H; Suzuki A; Watanabe G; Hirakawa H; Amari M; Kakugawa Y; Kawai M; Furuta A; Sato K; Yoshida R; Ebata A; Sasano H; Jingu K; Ohuchi N; Ishida T
Surg Oncol; 2017 Jun; 26(2):163-170. PubMed ID: 28577722
[TBL] [Abstract][Full Text] [Related]
12. Present-day locoregional control in patients with t1 or t2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapy.
Sharma R; Bedrosian I; Lucci A; Hwang RF; Rourke LL; Qiao W; Buchholz TA; Kronowitz SJ; Krishnamurthy S; Babiera GV; Gonzalez-Angulo AM; Meric-Bernstam F; Mittendorf EA; Hunt KK; Kuerer HM
Ann Surg Oncol; 2010 Nov; 17(11):2899-908. PubMed ID: 20443145
[TBL] [Abstract][Full Text] [Related]
13. [Prognosis and risk factors of 1 791 patients with breast cancer treated with breast-conserving surgery based on real-world data].
Chen SY; Tang Y; Song YW; Wang SL; Jin J; Liu YP; Wang WH; Fang H; Ren H; Sun GY; Wang JY; Jing H; Zhang JH; Liu XF; Yu ZH; Li YX
Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):619-625. PubMed ID: 30139034
[No Abstract] [Full Text] [Related]
14. Can a subgroup at high risk for LRR be identified from T1-2 breast cancer with negative lymph nodes after mastectomy? A meta-analysis.
Peng G; Zhou Z; Jiang M; Yang F
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31484798
[No Abstract] [Full Text] [Related]
15. Is biological subtype prognostic of locoregional recurrence risk in women with pT1-2N0 breast cancer treated with mastectomy?
Truong PT; Sadek BT; Lesperance MF; Alexander CS; Shenouda M; Raad RA; Taghian AG
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):57-64. PubMed ID: 24161421
[TBL] [Abstract][Full Text] [Related]
16. Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatment.
McBride A; Allen P; Woodward W; Kim M; Kuerer HM; Drinka EK; Sahin A; Strom EA; Buzdar A; Valero V; Hortobagyi GN; Hunt KK; Buchholz TA
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):392-8. PubMed ID: 24721590
[TBL] [Abstract][Full Text] [Related]
17. Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy.
Tendulkar RD; Rehman S; Shukla ME; Reddy CA; Moore H; Budd GT; Dietz J; Crowe JP; Macklis R
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e577-81. PubMed ID: 22560546
[TBL] [Abstract][Full Text] [Related]
18. Locoregional failure of postmastectomy patients with 1-3 positive axillary lymph nodes without adjuvant radiotherapy.
Cheng JC; Chen CM; Liu MC; Tsou MH; Yang PS; Jian JJ; Cheng SH; Tsai SY; Leu SY; Huang AT
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):980-8. PubMed ID: 11958892
[TBL] [Abstract][Full Text] [Related]
19. Predictors of locoregional outcome in patients receiving neoadjuvant therapy and postmastectomy radiation.
Wright JL; Takita C; Reis IM; Zhao W; Saigal K; Wolfson A; Markoe A; Moller M; Hurley J
Cancer; 2013 Jan; 119(1):16-25. PubMed ID: 22736498
[TBL] [Abstract][Full Text] [Related]
20. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer.
Truong PT; Olivotto IA; Speers CH; Wai ES; Berthelet E; Kader HA
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):797-804. PubMed ID: 14967436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
